Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 7—July 2013

Research

Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel

Daniel M. WeinbergerComments to Author , Noga Givon-Lavi, Yonat Shemer-Avni, Jacob Bar-Ziv, Wladimir J. Alonso, David Greenberg, and Ron Dagan
Author affiliations: Yale School of Public Health, New Haven, Connecticut, USA (D.M. Weinberger); National Institutes of Health, Bethesda, Maryland, USA (D.M. Weinberger, W.J. Alonso); Soroka University Medical Center, Beer-Sheva, Israel (N. Givon-Lavi, Y. Shemer-Avni, D. Greenberg); Ben-Gurion University of the Negev, Beer-Sheva (N. Givon-Lavi, Y. Shemer-Avni, D. Greenberg, R. Dagan); Hadassah University Medical Center, Jerusalem, Israel (J. Bar-Ziv)

Main Article

Table 1

RCAP incidence, southern Israel, 2004–2012*

Ethnicity; age, mo. RCAP, no. cases (incidence†)
Overall 2004–05 2005–06 2006–07 2007–08 2008–09 2009–10 2010–11 2011–12
Jewish
<6 285 (9.1) 23 (6.2) 32 (8.7) 41 (10.8) 48 (12.4) 38 (9.6) 51 (12.8) 35 (8.6) 17 (4.1)
6–17 958 (15.6) 128 (16.9) 123 (16.6) 112 (15.2) 157 (20.7) 117 (15.1) 120 (15.2) 120 (15.0) 81 (10.1)
17–35 1,003 (11.0) 106 (9.6) 140 (12.3) 130 (11.7) 181 (16.3) 119 (10.5) 127 (10.9) 106 (9.0) 94 (7.9)
Bedouin
<6 1,147 (39.9) 147 (41.9) 116 (33.9) 177 (51.1) 135 (37.9) 162 (44.5) 146 (39.6) 175 (47.0) 89 (23.7)
6–17 1,486 (26.0) 186 (25.7) 181 (25.8) 223 (32.6) 186 (26.9) 224 (31.4) 218 (29.9) 168 (22.8) 100 (13.5)
17–35 1,057 (12.4) 123 (11.5) 149 (13.7) 140 (13.3) 145 (14.1) 145 (14.0) 147 (13.8) 119 (10.9) 89 (8.1)

*RCAP, radiologically confirmed alveolar pneumonia.
†Number of cases/1,000 children/year.

Main Article

TOP